U.S., Nov. 5 -- An application to own the trademark for 'REKENCT' has been filed on Apr. 24, 2025.
Owner(s):
Kenai Therapeutics, Inc.; One Broadway 14th Floor, Kendall Square, , MASSACHUSETTS
Goods and/or Services:
For: Therapeutic pharmaceutical preparations for the treatment of neurodegenerative diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-11-04&serialNumber=99154221
Disclaimer: Curated by HT Syndication....